enow.com Web Search

  1. Ads

    related to: alternative treatment for macular degeneration nhs

Search results

  1. Results from the WOW.Com Content Network
  2. FDA Approves Biosimilars for Macular Degeneration Treatment - AOL

    www.aol.com/fda-approves-biosimilars-macular...

    The FDA approved two interchangeable biosimilars to treat macular degeneration. The biosimilars work the same way as Eylea which prevents abnormal blood vessel growth in the eye and helps preserve ...

  3. Anti-VEGF - Wikipedia

    en.wikipedia.org/wiki/Anti-VEGF

    This is done in the treatment of certain cancers and in age-related macular degeneration. They can involve monoclonal antibodies such as bevacizumab , antibody derivatives such as ranibizumab (Lucentis), or orally-available small molecules that inhibit the tyrosine kinases stimulated by VEGF: sunitinib , sorafenib , axitinib , and pazopanib ...

  4. Rheopheresis - Wikipedia

    en.wikipedia.org/wiki/Rheopheresis

    It is an experimental treatment for dry age-related macular degeneration, [2] and acute ischemic stroke. [3] References

  5. Stem cell therapy for macular degeneration - Wikipedia

    en.wikipedia.org/wiki/Stem_cell_therapy_for...

    Induced pluripotent stem cell taken from blood cell and converted in retinal pigment epithelium. Stem cell therapy for macular degeneration is an emerging treatment approach aimed at restoring vision in individuals suffering from various forms of macular degeneration, particularly age-related macular degeneration (AMD). [1]

  6. Macular degeneration - Wikipedia

    en.wikipedia.org/wiki/Macular_degeneration

    The incidence of age-related macular degeneration and its associated features increases with age and is low in people <55 years of age. [101] Smoking is the strongest modifiable risk factor. [102] As of 2008, age-related macular degeneration accounts for more than 54% of all vision loss in the white population in the US. [103]

  7. Cone dystrophy - Wikipedia

    en.wikipedia.org/wiki/Cone_dystrophy

    The fundus exam via ophthalmoscopy is essentially normal early on in cone dystrophy, and definite macular changes usually occur well after visual loss. Fluorescein angiography (FA) is a useful adjunct in the workup of someone suspected to have cone dystrophy, as it may detect early changes in the retina that are too subtle to be seen by ...

  1. Ads

    related to: alternative treatment for macular degeneration nhs